Reason for the notification
|
|
Initial
notification /Amendment
|
Initial
notification
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
Name
|
Smith
& Nephew plc
|
LEI
|
213800ZTMDN8S67S1H61
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
|
Description of the
financial instrument, type of instrument
|
Smith
& Nephew plc ordinary shares of USD 0.20 each
|
Identification
code
|
ISIN:
GB0009223206
|
Nature
of the transaction
|
Partial
vesting on 12 August 2025 of Conditional Share awards granted on 11
August 2023 under the Smith & Nephew Global Share Plan 2020,
and subsequent sale of shares to cover tax liability
|
Date
of Transaction
|
2025
- 08 - 12
|
Place
of Transaction
|
London
Stock Exchange (XLON)
|
Name
(Position)
|
Status
|
Price (£)
|
Volume
|
Aggregated information
|
Rohit
Kashyap
(President,
Advanced Wound Management and Global
|
PDMR
|
13.571365
|
23,201
(of which 5,670 were sold and 17,531 were retained.)
|
N/A
Single Transaction
|
|
|
|
|
|
Smith & Nephew plc
|
|
|
(Registrant)
|
|
|
|
|
|
|
Date:
August 13, 2025
|
By:
|
/s/
Helen Barraclough
|
|
|
Helen
Barraclough
|
|
|
Company
Secretary
|